Hemothorax surgery

Jump to navigation Jump to search

Hemothorax Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemothorax from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemothorax surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemothorax surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemothorax surgery

CDC on Hemothorax surgery

Hemothorax surgery in the news

Blogs on Hemothorax surgery

Directions to Hospitals Treating Hemothorax

Risk calculators and risk factors for Hemothorax surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Irfan Dotani Joanna Ekabua, M.D. [2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The successful management of hemothorax depends on the severity of the blood loss and subsequent hemodynamic stability of the patient. The mainstay of therapy for a hemothorax is intercostal chest drain (ICD) and oxygen therapy that significantly reduce the morbidity and mortality. Evacuation of haemothorax by chest tube does not succeed in all cases. The resultant retained intrapleural collections are referred to as residual hemothorax (RH). Blood in the pleural cavity may organize and fibrosis, resulting in a loss of lung volume and empyema if untreated. Video assisted thoracic surgery (VATS), minimally invasive surgery, has been found to be highly successful for the treatment of these residual collections, especially when used early. VATS also can be used to treat patients with active blood loss but with stable hemodynamics, not only to stop the bleeding but also to evacuate blood clots and break down adhesions to prevent fibrothorax and restrictive physiology. An optimal period between the start of haemothorax and VATS of 48–72 hrs is repeatedly advocated and longer intervals lead to increased rates of complications, according to some authors. A longer time span increases the chance of intraoperative conversion to thoracotomy, prolongs postoperative drainage time and is associated with a higher incidence of hospital admissions. Thoracotomy with ongoing resuscitation is the procedure of choice for patients with hemodynamic instability due to massive haemothorax or active bleeding. The criteria for thoracotomy, are blood loss by chest tube of 1.500 ml in 24 h or 200 ml per hour during several successive hours and the need for repeated blood transfusions to maintain hemodynamic stability. Surgical exploration allows control of the source of bleeding and evacuation of the intrathoracic blood; and also is required for adequate empyema drainage and/or decortication.

Surgery

References

Template:WH Template:WS